Details for New Drug Application (NDA): 021087
✉ Email this page to a colleague
The generic ingredient in TAMIFLU is oseltamivir phosphate. There are eight drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the oseltamivir phosphate profile page.
Summary for 021087
Tradename: | TAMIFLU |
Applicant: | Roche |
Ingredient: | oseltamivir phosphate |
Patents: | 0 |
Pharmacology for NDA: 021087
Mechanism of Action | Neuraminidase Inhibitors |
Medical Subject Heading (MeSH) Categories for 021087
Suppliers and Packaging for NDA: 021087
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TAMIFLU | oseltamivir phosphate | CAPSULE;ORAL | 021087 | NDA | A-S Medication Solutions | 50090-0662 | 50090-0662-0 | 1 BLISTER PACK in 1 CARTON (50090-0662-0) / 10 CAPSULE in 1 BLISTER PACK |
TAMIFLU | oseltamivir phosphate | CAPSULE;ORAL | 021087 | NDA | Redpharm Drug | 67296-0131 | 67296-0131-1 | 1 BLISTER PACK in 1 CARTON (67296-0131-1) / 10 CAPSULE in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 75MG BASE | ||||
Approval Date: | Oct 27, 1999 | TE: | AB | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 45MG BASE | ||||
Approval Date: | Jul 2, 2007 | TE: | AB | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 30MG BASE | ||||
Approval Date: | Jul 2, 2007 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 021087
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Roche | TAMIFLU | oseltamivir phosphate | CAPSULE;ORAL | 021087-003 | Jul 2, 2007 | ⤷ Sign Up | ⤷ Sign Up |
Roche | TAMIFLU | oseltamivir phosphate | CAPSULE;ORAL | 021087-002 | Jul 2, 2007 | ⤷ Sign Up | ⤷ Sign Up |
Roche | TAMIFLU | oseltamivir phosphate | CAPSULE;ORAL | 021087-002 | Jul 2, 2007 | ⤷ Sign Up | ⤷ Sign Up |
Roche | TAMIFLU | oseltamivir phosphate | CAPSULE;ORAL | 021087-001 | Oct 27, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Roche | TAMIFLU | oseltamivir phosphate | CAPSULE;ORAL | 021087-001 | Oct 27, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Roche | TAMIFLU | oseltamivir phosphate | CAPSULE;ORAL | 021087-001 | Oct 27, 1999 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription